Printer Friendly

Physicians are frustrated with preauthorization.

More than two-thirds of physicians reported that they have had to wait several days for insurers to conduct prior authorization reviews for tests, procedures, and prescription drugs, and about the same proportion have had difficulty tracking which of these therapeutics are subject to review requirements, according to a national survey of physicians released by the American Medical Association.

Although physicians are frequently said to be frustrated by insurers' review requirements, this is the AMA's first national survey to measure physicians' experiences. The survey of 2,400 practitioners was conducted in May.

Nearly all physicians would like to eliminate impediments caused by preauthorization requirements, with 78% saying it is "very important" and an additional 17% saying it is "important" for insurers to eliminate preauthorization hassles.

Among the findings were the following:

* More than half (58%) of physicians experienced difficulty with obtaining approval from insurers on a quarter or more of preauthorization requests.

* 57% experienced a 20% rejection rate on first-time preauthorization requests.

* Just under 40% reported appealing 80% or more of insurer rejections on first-time preauthorization requests.

Physicians spend about 20 hr/wk dealing just with preauthorizations, according to the survey. Many (75%) expressed a desire for plans to implement an automated preauthorization process.

Scott Steinke is with "The Pink Sheet." This newspaper and "The Pink Sheet" are published by Elsevier.

COPYRIGHT 2011 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:PRACTICE TRENDS
Author:Steinke, Scott
Publication:Family Practice News
Article Type:Brief article
Geographic Code:1USA
Date:Feb 1, 2011
Words:220
Previous Article:Medicare launches physician compare Web site.
Next Article:Risk of prostate cancer death reduced with low initial PSA: findings may support substantially longer intervals of PSA screening.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters